Do you have any queries?

or Call us now at 9982-782-555

back-arrow-image Search Health Packages, Tests & More

Prenatal Chromosomal Array CGH Test

50+ booked in last 3 days

CGH Chromosome Array Test Overview

Chromosomal Array, Comparative genomic hybridization (CGH) is a confirmatory & an invasive test which is done prenatally to identify foetal anomalies i.e., chromosomal aneuploidy, other large structural changes, sub microscopic abnormalities that are not detected by karyotyping. CGH Chromosome Array Test requires detailed clinical history including anomaly scan report and a duly filled consent form (Form G)

Array CGH Prenatal helps in the detection of copy number variations (CNV) changes (microdeletions and microduplications).

Conventional karyotyping is used to detect chromosomal problems in about 35% of pregnancies. However, its accuracy depends on the quantity and type of fetal ultrasonography anomalies present. Prenatal karyotyping is a reliable procedure that can identify the majority of germline chromosomal abnormalities. Most of these anomalies are associated with the phenotype. For postnatal diagnosis of people with congenital defects and intellectual incapacity, array-comparative genomic hybridization (CGH)/(single nucleotide polymorphism is very common. It has a high probability of accurate abnormality detection and is automation-friendly. This makes it the perfect choice for a prenatal diagnosis.

To discover fetal defects such as chromosomal aneuploidy, other significant structural changes, and submicroscopic abnormalities that are not picked up by karyotyping, a confirming and invasive test called CGH is performed during pregnancy. A complete consent form and a clinical history that includes the anomaly scan report are required for the test (Form G).

CGH has been established to aid in prenatal diagnosis. It is used to examine structural chromosomal rearrangements linked to copy number variations on a genome-wide scale. Test and standard genomic DNAs are fluorescently labeled with two separate fluorochromes and hybridized to healthy metaphase chromosomes in CGH. Genome-wide copy number alterations, such as homo- or heterozygous deletions, gains, or amplifications, can be detected by determining the relative genomic copy number throughout each chromosome.

Written by: Dr Vishal Wadhwa M.D, D.N.B Microbiology, Medical Affairs

Read More

Prenatal Chromosomal Array CGH Test Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Prenatal Chromosomal Array CGH Test with a clear pricing structure.

The Prenatal Chromosomal Array CGH Test Price in Mumbai is ₹ 16,800 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

To determine the risk for the fetus being born with certain Genetic (chromosomal) abnormalities.
Patients at high-risk in biochemical maternal screen markers, patients with abnormal foetal USG findings can be offered array CGH.
This technique is not limited by tissue culture failure which affects traditional techniques like karyotyping

This test is conducted for the following reasons:

  1. It estimates the likelihood that the fetus will have specific genetic (chromosomal) abnormalities.
  2. Array CGH test is recommended for patients with aberrant fetal ultrasonography findings and at high risk for biochemical prenatal screen markers.

This method is not constrained by tissue culture failure, which compromises more established methods like karyotyping.

Prenatal testing should be made available to all women, along with the choice of invasive procedures. It should be done for any pregnancy for which conventional karyotyping would be recommended. Chromosomal microarray testing (aCGH) must be taken into consideration if the woman feels that her risk is high enough to warrant invasive testing.

Common considerations include:

  • Older maternal age.
  • Aberrant screening test results indicate a higher risk for a chromosomal disorder.
  • Previous babies or pregnancies with a documented chromosomal abnormality.
  • Unexpected ultrasound findings.
  • Prior miscarriages or stillbirths.

cgh chromosome array test detects chromosomal aneuploidy, large chromosomal change, sub microscopic abnormalities, copy number variation (CNV)

This test measures the following markers:

  1. Chromosome aneuploidy.
  2. Significant chromosomal changes.
  3. Submicroscopic abnormalities.
  4. Copy number variation.

Your doctor will guide you on sample collection. Possible samples are amniotic fluid (20 mL), 20 mg of chorionic villus sample, prenatal cord blood in EDTA, Maternal blood sample in EDTA is mandatory. Samples should be refrigerated at 2-8 ?C but not frozen. Form G is mandatory for carrying out prenatal genetic test

Maternal blood in EDTA is also required. Samples must be kept chilled, but not frozen, at 2--8°C. Form G must be completed to do a prenatal genetic test.

CGH can detect aneuploidies like Trisomy's, large deletions & copy number variants. Patients must consult their doctor/ genetic counsellor to understand the significance of the reported findings.
This technique will not detect balanced chromosome rearrangements (which do not result in deletion or duplication of genetic material) and low level mosaicism

All women should have access to prenatal testing. Women must also be given the option of invasive procedures. aCGH should be considered for any pregnancy in which standard karyotyping would be advised if the woman feels her risk is high enough to call for invasive testing.

aCGH should be taken into consideration for any pregnancy for which routine karyotyping is available. However, many medical professionals and genetic counselors also regularly consider using an array of CGH technology for pregnancies in which an anomaly is seen by ultrasound evaluation

The doctor will guide the patient regarding the steps of the test.

Most additional or missing chromosomes can be found by employing both a karyotype and a chromosomal microarray test.

Recent investigations have determined that there is a 1% chance of having a chromosome with an additional or missing section. This risk is not age-related. A karyotype can pick up some of these alterations. However, the majority are too tiny to be observed using a microscope. Most excess or missing chromosome segments can be found using the aCGH test.

Prenatal Array CGH

Array-comparative genomic hybridization


full medical check up

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

lab image
170+ Advanced Labs
lab image
Trusted by Leading Doctors & Hospitals
lab images
Over 2000+ Scientific Officers
reports image
Proficiency Testing for Accurate Reports

Our Blog

Take a look at some of the related content from our blog

Latest Blogs & News

View More
View all